Study ID: Incyte BMS INCB24360-204 Advanced Tumors
A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers
Sioux Falls Region
James Kuzman, MD
Other, NHL (Non-Hodgkins Lymphoma)
Active - Open to Accrual
For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.